This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Asia: Oligonucleotide & Peptide Therapeutics Scientific Forum
19-21 March 2024
Westin Miyako KyotoKyoto, Japan

Jennifer Lockridge, PhD
VP, Dicerna TRU Early Development at Novo Nordisk

Agenda Sessions

  • Chairperson’s Remarks

  • From Bench to Bedside: Development of a GalXC-Plus siRNA, DCR-STAT3, for Immunotherapy in Refractory Cancer Patients